Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:80 |
|---|---|
| Enthalten in: |
The Journal of infection - 80(2020), 5 vom: 01. Mai, Seite 578-606 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
May, Shoshanna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.03.2021 Date Revised 18.03.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2020.01.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30613392X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30613392X | ||
| 003 | DE-627 | ||
| 005 | 20231225122708.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2020.01.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1020.xml |
| 035 | |a (DE-627)NLM30613392X | ||
| 035 | |a (NLM)32017973 | ||
| 035 | |a (PII)S0163-4453(20)30035-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a May, Shoshanna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2021 | ||
| 500 | |a Date Revised 18.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Ribavirin |2 NLM | |
| 650 | 7 | |a 49717AWG6K |2 NLM | |
| 700 | 1 | |a Kurmoo, Feza |e verfasserin |4 aut | |
| 700 | 1 | |a Iliffe, Mariesa |e verfasserin |4 aut | |
| 700 | 1 | |a David, Joicy |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Ayushi |e verfasserin |4 aut | |
| 700 | 1 | |a Wiselka, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Stephenson, Iain |e verfasserin |4 aut | |
| 700 | 1 | |a Delahooke, Toby |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Florence Y |e verfasserin |4 aut | |
| 700 | 1 | |a Dustan, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Julian W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 80(2020), 5 vom: 01. Mai, Seite 578-606 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:80 |g year:2020 |g number:5 |g day:01 |g month:05 |g pages:578-606 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.01.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 80 |j 2020 |e 5 |b 01 |c 05 |h 578-606 | ||